MELLESSA LURCH: Open Payments
NPI 1801227822 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$788 in 19 payments from 5 companies in 2025. Trend: 2023 $521 · 2024 $709 · 2025 $788
Food & beverage: $788
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $484 |
| ABBVIE INC. | 3 | $158 |
| ORPHALAN INC | 2 | $83 |
| Madrigal Pharmaceuticals | 1 | $33 |
| Intercept Pharmaceuticals, Inc. | 1 | $31 |
Products named: MAVYRET, CUVRIOR, REZDIFFRA, OCALIVA.
Industry payments across NY — which companies pay providers there.
